Can a 4-Week drug course tame Post-Surgery heart flutters?
NCT ID NCT05841056
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a short course of amiodarone can reduce the return and burden of atrial fibrillation (AF) in 400 adults who develop new AF after heart surgery. Participants receive either standard care or amiodarone for 4 weeks. The goal is to see if this approach is practical and effective in controlling AF without long-term medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION NEW ONSET are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hamilton General Hospital
RECRUITINGHamilton, Ontario, L8L 2X2, Canada
-
St. Michael's Hospital
RECRUITINGToronto, Ontario, M5B 1C9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an AI spot a heart rhythm disorder two hours before it happens?
- Bypass patients may avoid A-Fib with one extra cut
- Old gout drug may keep heart in rhythm after valve surgery
- Heart rhythm watch: do ICU patients face hidden AF risk after leaving hospital?
- Heart attack patients monitored for hidden rhythm disorder
- Heart patch could spot silent stroke risk in elderly women